AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
KETAMINE HYDROCHLORIDE USP
3 registrations across 3 African markets— 2 active
Markets with KETAMINE HYDROCHLORIDE USP
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| CIROKET Injection | 🇰🇪Kenya | CIRON DRUGS AND PHARMACEUTICALS PVT. LTD. | active | Jan 2031 |
| KETAMAX 50 Solution for injection | 🇷🇼Rwanda | TROIKAA PHARMACEUTICALS LTD | active | Jul 2029 |
| KETAMAX-50 50MG/VIAL INJECTION INJECTION | 🇲🇼Malawi | — | expired | Mar 2025 |
KETAMINE HYDROCHLORIDE USP in Africa — Regulatory Overview
KETAMINE HYDROCHLORIDE USP is registered across 3 African markets with 3 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Kenya, Malawi, Rwanda. AfricaRegulatory refreshes this data daily from official government sources.
Of the 3 registrations, 2 (67%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.